WICKLIFFE, Ohio—Lubrizol Corp. has acquired Laboratoire Phenobio, a French supplier of "naturally-derived extracts and botanical active ingredients," according to a news release.
The terms of the deal are not being disclosed.
The acquisition will support Lubrizol's abilities to offer natural products to the cosmetic, nutraceutical and life sciences industries, and the technologies Laboratoire Phenobio uses supports the company's sustainability efforts. That includes a technology known as pressurized low polarity water, which the release said is used to "extract phytoactives from botanical raw materials."
"Lubrizol continues to invest in innovative technologies to offer step change formulations for the personal care and life sciences markets," Deb Langer, Lubrizol vice president and general manager of personal, home and health care, said in the release. "With this acquisition, Lubrizol customers will have access to novel botanical extracts compliant with Ecocert and Cosmos standards that meet the naturality and sustainability expectations end users are requiring on a global basis. Additionally, our preferred partners will have access to final formulations using this exciting new technology."
Lubrizol owns and operates manufacturing facilities in 17 countries, as well as sales and technical offices around the world. It has about 8,700 employees worldwide. Revenues for 2018 were $6.8 billion.